754221
Last Update Posted: 2019-12-17
Recruiting has ended
All Genders accepted | 18 Years + |
390 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Open Label Extension Study of [S,S]-Reboxetine in Patients With Fibromyalgia
This is a study to investigate the long-term safety and effectiveness [S,S]-Reboxetine in relieving the symptoms of Fibromyalgia in patients.
Eligibility
Relevant conditions:
Fibromyalgia
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov